🇺🇸 FDA
Patent

US 10584135

Substituted 3,6-diazabicyclo[3.2.0]heptanes

granted A61PA61P25/18A61P25/32

Quick answer

US patent 10584135 (Substituted 3,6-diazabicyclo[3.2.0]heptanes) held by Indivior UK Limited expires Mon Mar 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Indivior UK Limited
Grant date
Tue Mar 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61P, A61P25/18, A61P25/32, A61P25/36